Overview

A Trial of HRS-7450 in Chinese Healthy Volunteers

Status:
Not yet recruiting

Trial end date:
2023-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this First-in-Human study is to evaluate the safety and tolerability after single ascending doses of HRS-7450 given to healthy subjects, compared to placebo..

Phase:

Phase 1

Details

Lead Sponsor:

Fujian Shengdi Pharmaceutical Co., Ltd.